Centessa Pharmaceuticals plc Stock
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
+1.20% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.49B 5.06B 4.74B 8.89B 591B 9.08B 60.87B 23.55B 292B 23.53B 23.02B 1,013B | P/E 2026 * |
-26x | P/E 2027 * | -22.6x |
|---|---|---|---|---|---|
| Enterprise Value | 6.27B 5.49B 5.06B 4.74B 8.89B 591B 9.08B 60.87B 23.55B 292B 23.53B 23.02B 1,013B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
78.43% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.80% | ||
| 1 week | +1.20% | ||
| Current month | +1.86% | ||
| 1 month | +1.81% | ||
| 3 months | +37.76% | ||
| 6 months | +59.89% | ||
| Current year | +61.94% |
| 1 week | 39.98 |  | 40.56 |
| 1 month | 39.58 | | 40.56 |
| Current year | 21.5 | | 40.56 |
| 1 year | 12.78 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 24/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 24/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-24 | Issuer sale | Compliance Officer | -1,376,483 | 0.8896% | ||
| 06-24 | Issuer sale | Director | -711,155 | 0.4596% | ||
| 06-24 | Issuer sale | Director | -392,474 | 0.2537% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | +1.20% | +210.58% | +486.96% | 6.27B | |
| -0.48% | +7.20% | -5.08% | +2.45% | 46.2B | |
| +2.19% | +11.71% | +385.81% | +632.13% | 38.71B | |
| +2.53% | +13.93% | +20.85% | -10.61% | 31.9B | |
| +1.65% | +3.61% | +9.98% | +55.42% | 31.12B | |
| -4.16% | -2.58% | +8.74% | +15.22% | 23.77B | |
| -0.32% | +12.96% | - | - | 16.2B | |
| +1.37% | +14.53% | +71.80% | +134.14% | 15.05B | |
| +1.00% | +10.30% | +13.31% | +22.84% | 13.74B | |
| +3.63% | +9.53% | +104.07% | +107.62% | 13.42B | |
| Average | +0.82% | +8.41% | +91.12% | +160.68% | 23.64B | |
| Weighted average by Cap. | +0.76% | +8.53% | +90.21% | +150.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -237M -208M -192M -180M -337M -22.39B -344M -2.31B -892M -11.06B -891M -872M -38.37B | -265M -233M -215M -201M -377M -25.04B -384M -2.58B -998M -12.38B -997M -975M -42.91B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/06/26 | $40.50 | +0.80% | 11,330,436 |
| 22/06/26 | $40.18 | +0.40% | 3,758,569 |
| 18/06/26 | $40.02 | +0.38% | 5,588,743 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
